TOMMISHEA MAY: Open Payments
NPI 1669747622 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 65 payments from 19 companies in 2025. Trend: 2023 $473 · 2024 $1,484 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $208 |
| Dexcom, Inc. | 13 | $157 |
| Novo Nordisk Inc | 9 | $147 |
| Lilly USA, LLC | 8 | $139 |
| Astellas Pharma US Inc | 5 | $109 |
| Corcept Therapeutics | 3 | $54 |
| PFIZER INC. | 3 | $45 |
| Lundbeck LLC | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, Ozempic, Veozah, JARDIANCE, MOUNJARO, Korlym, REXULTI.
Industry payments across AL — which companies pay providers there.
